ATE466583T1 - Viskoelastische substanzen zur verwendung bei mittelohr operationen - Google Patents

Viskoelastische substanzen zur verwendung bei mittelohr operationen

Info

Publication number
ATE466583T1
ATE466583T1 AT01920347T AT01920347T ATE466583T1 AT E466583 T1 ATE466583 T1 AT E466583T1 AT 01920347 T AT01920347 T AT 01920347T AT 01920347 T AT01920347 T AT 01920347T AT E466583 T1 ATE466583 T1 AT E466583T1
Authority
AT
Austria
Prior art keywords
middle ear
ear surgery
viscoelastic substances
viscoelastic
surgical
Prior art date
Application number
AT01920347T
Other languages
English (en)
Inventor
Masoud Jafari
Uday Doshi
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE466583T1 publication Critical patent/ATE466583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/14—Materials or treatment for tissue regeneration for ear reconstruction or ear implants, e.g. implantable hearing aids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT01920347T 2000-03-14 2001-03-14 Viskoelastische substanzen zur verwendung bei mittelohr operationen ATE466583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18917900P 2000-03-14 2000-03-14
PCT/US2001/008064 WO2001068079A2 (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery

Publications (1)

Publication Number Publication Date
ATE466583T1 true ATE466583T1 (de) 2010-05-15

Family

ID=22696258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01920347T ATE466583T1 (de) 2000-03-14 2001-03-14 Viskoelastische substanzen zur verwendung bei mittelohr operationen

Country Status (13)

Country Link
US (1) US6632423B2 (de)
EP (1) EP1267894B1 (de)
JP (1) JP4746244B2 (de)
AT (1) ATE466583T1 (de)
AU (2) AU4741001A (de)
BR (1) BR0109162A (de)
CA (1) CA2402652C (de)
DE (1) DE60142031D1 (de)
ES (1) ES2343402T3 (de)
HK (1) HK1048765A1 (de)
MX (1) MXPA02008966A (de)
WO (1) WO2001068079A2 (de)
ZA (1) ZA200206696B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
PT1997478E (pt) * 2001-02-15 2013-12-10 Access Pharma Inc Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
US20040118414A1 (en) 2002-12-20 2004-06-24 Shah Mandar V Surface modified viscoelastics for ocular surgery
US7363928B2 (en) 2001-12-21 2008-04-29 Alcon, Inc. Dilution resistant viscoelastic compositions
DE60209144T2 (de) * 2001-12-21 2006-08-17 Alcon Inc. Viskoelastische ophthalmische zubereitungen enthaltend hyaluronsäure und chondroitinsulfat
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
US20060003964A1 (en) * 2004-06-30 2006-01-05 Shah Mandar V Dilution resistant viscoelastic compositions
US7297786B2 (en) * 2004-07-09 2007-11-20 University Of Iowa Research Foundation RNA interference in respiratory epitheial cells
US8313762B2 (en) * 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
WO2009132229A2 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Cold ionizing radiation sterilization
CN102883715B (zh) 2008-04-24 2014-11-12 麦德托尼克公司 包含壳聚糖的保护性组合物
CN102065849B (zh) * 2008-04-24 2015-04-29 麦德托尼克公司 基于壳聚糖和氧化多糖的保护性凝胶
JP2011518837A (ja) 2008-04-24 2011-06-30 メドトロニック，インコーポレイテッド 再水和可能なチオール化多糖粒子およびスポンジ
US8030297B2 (en) 2008-05-14 2011-10-04 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
CN102112112A (zh) * 2008-07-21 2011-06-29 奥德纳米有限公司 用于治疗耳部病症的受控释放抗微生物组合物和方法
US8318817B2 (en) * 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US10806833B1 (en) * 2009-05-11 2020-10-20 Integra Lifesciences Corporation Adherent resorbable matrix
US9326943B1 (en) 2009-06-23 2016-05-03 Sandra M. Skovlund Biodegradable prosthesis
CA2825757C (en) * 2011-02-02 2019-09-03 The Charles Stark Draper Laboratory, Inc. Drug delivery apparatus
EP2596796B1 (de) 2011-11-24 2013-11-13 Quimera Ingenieria Biomedica, S.L. Komplex erhalten aus Hyaluronsäure oder deren Salzen und Chondroitin-Sulfatmischungen
JP2016534121A (ja) 2013-08-27 2016-11-04 オトノミ—，インク． 小児の耳の病気の処置
CN105903087A (zh) * 2015-12-14 2016-08-31 上海其胜生物制剂有限公司 一种兼具内聚性和弥散性的粘弹剂的制备方法
EP3512513A4 (de) 2016-09-16 2020-04-15 Otonomy, Inc. Gelformulierungen für das ohr zur behandlung von otitis externa
CN106821980B (zh) * 2017-02-17 2019-10-18 成都博创必成生物技术有限公司 一种鼻腔喷雾剂及其制备方法和生物阻隔膜
KR20220041143A (ko) 2019-07-31 2022-03-31 아스텔라스세이야쿠 가부시키가이샤 귀내 투여용의 의약 조성물
CN114224609B (zh) * 2021-12-14 2024-01-30 曹佩培 一种中耳/咽鼓管防粘连膜及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US6051560A (en) 1986-06-26 2000-04-18 Nestle S.A. Chrondroitin sulfate/sodium hyaluronate composition
ES2064439T3 (es) * 1988-05-02 1995-02-01 Project Hear Material adhesivo quirurgico.
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US5273056A (en) * 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
CA2161774C (en) 1993-04-30 2000-01-04 Nestle S.A. Synthetic viscoelastic material for ophthalmic applications
US5501706A (en) * 1994-11-29 1996-03-26 Wildflower Communications, Inc. Medical implant structure and method for using the same
US5811453A (en) * 1994-12-23 1998-09-22 Alcon Laboratories, Inc. Viscoelastic compositions and methods of use
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides

Also Published As

Publication number Publication date
US20020169142A1 (en) 2002-11-14
CA2402652A1 (en) 2001-09-20
MXPA02008966A (es) 2003-02-12
EP1267894A2 (de) 2003-01-02
ES2343402T3 (es) 2010-07-30
CA2402652C (en) 2008-11-18
AU2001247410B2 (en) 2005-05-12
ZA200206696B (en) 2003-08-21
WO2001068079A2 (en) 2001-09-20
AU4741001A (en) 2001-09-24
DE60142031D1 (de) 2010-06-17
JP4746244B2 (ja) 2011-08-10
JP2003534036A (ja) 2003-11-18
WO2001068079A3 (en) 2002-07-25
EP1267894B1 (de) 2010-05-05
HK1048765A1 (zh) 2003-04-17
BR0109162A (pt) 2005-01-11
US6632423B2 (en) 2003-10-14

Similar Documents

Publication Publication Date Title
ATE466583T1 (de) Viskoelastische substanzen zur verwendung bei mittelohr operationen
EP1485381B8 (de) Azolylaminoazine als inhibitoren von proteinkinasen
WO2007002390A3 (en) Compositions and methods for modulation of smn2 splicing
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
EP2497478A3 (de) Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
AU2003231022A1 (en) Improved membrane for use in sutured or sutureless surgical procedures
WO2005028475A3 (en) Compositions useful as inhibitors of protein kinases
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
HRP20150828T1 (xx) Kompozicije i postupci in vitro i in vivo ciljanog oslobađanja lijeka u stanicama sisavaca, preko intaktnih mini-stanica izvedenih iz bakterija
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
DE60141964D1 (de) Bandscheibe
WO2007100459A3 (en) Surgical slings
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
AU2001273475A1 (en) Coagulator and spinal disk surgery
DE60019389D1 (de) Chirurgischer Schwenkhaltering zur Verwendung in der Augenchirurgie
WO2002098361A3 (en) T cell induced tissue repair and regeneration
EP2384764A3 (de) Zusammensetzungen und Verfahren zur Hämostase-Modulierung mit Hilfe varianter Formen des aktivierten Faktors V
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
TR200200278T2 (tr) Kalsilitik bileşimler
EP1330271A4 (de) Verwendung von transkriptionsfaktoren zur behandlung von entzündungen und anderen erkrankungen
AU2003242360A1 (en) Culture apparatus, artificial tissue and blood preparation
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
WO2007005659A3 (en) Methods and compositions for culturing keratinocytes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties